“[Patients]… need to understand what they’re gaining and what they’re giving up,” says Samuel J. Peretsman, MD, in this video.
In this video, the second installment of Urology Times® Editorial Consultant J. Brantley Thrasher, MD,’s recent interview with Samuel J. Peretsman, MD, regarding high-intensity focused ultrasound, Peretsman explains what he tells patients undergoing HIFU to expect postoperatively. Peretsman is with Urology Specialists of the Carolinas in Charlotte, North Carolina, and Thrasher is executive director of the American Board of Urology.
More videos:
HIFU for prostate cancer: How it works, criteria for treatment, and contraindications
Attorney Kenton H. Steele, Esq, on the medico-legal dangers of friendly prescribing
Dr. Kathleen Kieran discusses peer-reviewed authorship for women in urology
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.